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AbstrAct
Objective The objective of the study was to investigate 
the symptoms people with diabetes experience when 
having a myocardial infarction (MI), their illness narrative 
and how they present their symptoms to the health 
service.
setting Three London (UK) hospitals (coronary care units 
and medical wards).
Participants Patients were recruited with diabetes 
mellitus (DM) (types 1 and 2) with a clinical presentation of 
MI (ST elevated MI (STEMI), non-ST elevated MI (NSTEMI), 
acute MI unspecified and cardiac arrest). A total of 43 
participants were recruited, and 39 interviews met the 
study criteria and were analysed. They were predominantly 
male (n=30), aged 40–90 years and white British (18/39), 
and just over a half were from other ethnic groups. The 
majority had type 2 DM (n=35), 24 had an NSTEMI, 10 had 
an STEMI and five had other cardiac events.
Definitions of selection/exclusion criteria A diagnosis 
of MI and DM and the ability to communicate enough 
English to complete the interview. Ward staff made a 
clinical judgement that the participant was post-treatment, 
clinically stable and well enough to participate.
Methods A qualitative study using taped and transcribed 
interviews analysed using a thematic analysis.
results While most participants did experience chest 
pain, it was often not their most striking symptom. As 
their chest pain did not match their expectations of 
what a ‘heart attack’ should be, participants developed 
narratives to explain these symptoms, including the 
symptoms being effects of their DM (‘hypos’), side effects 
of medication (oral hypoglycaemics) or symptoms (such 
as breathlessness and indigestion) related to other 
comorbidities, often leading to delays in seeking care.
conclusions While truly absent chest pain during MI 
among people with DM was rare in this study, patients’ 
attenuated symptoms often led to delay in seeking 
attention, and this may result in delays in receiving 
treatment.
bAckgrOunD
Diabetes mellitus (DM) is a common health 
problem worldwide and affects 4%–6% of the 
UK population.1 Cardiovascular disease is the 
major life-threatening complication of DM in 
the UK.2–4 Myocardial infarction (MI) is the 
prime cause of excess mortality among those 
with DM, with a threefold increased risk of 
coronary heart disease (CHD) mortality,5 6 a 
sixfold increased risk of MI7 and a worse prog-
nosis from MI compared with populations 
without diabetes.8
Possible mechanisms of this excess 
mortality risk include comorbidities such as 
hypertension, dyslipidaemia and chronic 
kidney disease. An important element in this 
observed increased mortality may be late or 
missed presentation by patients and diagnosis 
by clinicians.9–11
Up to a third of people who suffer an MI 
can have no chest pain; however, people with 
DM make up a larger proportion of this group 
(32.6% vs 25.4% in one study).12 However, 
when people with DM do have symptoms of 
an MI, their symptoms may often be atypical13 
or unusual.14 Nevertheless, there is conflicting 
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Research
strengths and limitations of this study
 ► Contemporaneous patients’ descriptions of their 
symptoms and illness narrative just after an 
myocardial infarction (MI).
 ► A model of how attenuated MI symptoms might alter 
help-seeking behaviour.
 ► The participants were from a wide demographic 
background in terms of age, ethnicity and disease 
burden.
 ► By recruiting patients from coronary care units, 
we will not have captured markedly discrepant 
presentations.
 ► By recruiting on the basis of the ability to 
communicate in English, we will have lost 
some cultural and linguistic nuance in symptom 
presentation.
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evidence around this issue: Funk found no statistically 
significant difference in CHD symptom presentation in 
people with and without DM but did report non-significant 
increases in dyspnoea, neck and throat pain among those 
with DM.15 Kentsch found no differences between these 
groups in the frequency or severity of chest pain but also 
identified differences in the prevalence of dyspnoea.16 One 
review found conflicting results about differing MI symp-
toms among women with and without DM.17
There are several methodological reasons why these 
studies may have conflicting results: being underpow-
ered,18 19 being unrepresentative of the population at 
risk18 or being recruited from highly selected hospital 
populations.20 Survivor bias (ie, living to tell the tale 
of your symptoms) may also be an important issue in a 
condition such as MI which has a high early mortality.21
There is a biological basis for altered perception of pain 
among people with diabetes in that cardiac autonomic 
neuropathy is a complication of DM and leads to altered 
pain perception, meaning a patient might not experience 
pain caused by myocardial ischaemia.20
Several qualitative studies have explored patients’ 
symptoms during MI.18 22–26 Within the general popula-
tion experiencing MI, there are several issues identified 
including the considerable psychological impact of pain 
and specifically cardiac pain,27 cardiac symptoms that 
can be interpreted as pain but also can trigger symptoms 
such as anxiety (both as a trigger and barrier to action) 
and fear,28 producing responses like uncertainty29 and 
denial.30 Further factors identified include patients not 
recognising their symptoms as MI, experiencing vague 
symptoms,31 misattributing their symptoms,23 24 erroneous 
expectations of an MI31 and the decisions patients make 
during their MI.32 Other factors include delays in seeking 
care.11 30 Theoretical models of delay in seeking treat-
ment specifically in relation to MI have been summarised 
by Dracup.33 Underestimating personal risk of an MI23 
and perceived lack of vulnerability to heart disease link to 
the concept of ‘lay epidemiology’ and of ‘coronary candi-
dacy’, that is, not fitting individual's assumptions about 
the sort of person who gets a heart attack.34
There is a role of gender with MI symptoms and its 
interpretation; work exploring women’s experience of 
MI symptoms found that women with diabetes had more 
atypical and painless MIs than men. In studies of denial 
among men with chest pain, there has been exploration 
of the impact of their gender roles adversely effecting 
health-seeking behaviour.35
In studies specifically exploring the experience of 
patient with diabetes and MI, many similar themes emerge. 
However, Angerud finds a variability in the experience of 
MI symptoms while exploring the patients’ response to 
symptoms, perceived susceptibility and symptom interpre-
tation (but found that MI symptoms were rarely ascribed 
to DM).25 Other studies in this population also identify 
breathlessness as a presenting symptom, misinterpretation 
of symptoms and their diabetes influencing patients’ deci-
sion making during events.36
clinician factors
The way clinicians ask about chest symptoms may be 
problematic. Clinicians ask about ‘chest pain’; however, 
the term ‘pain’37 38 is often not used by patients experi-
encing MI.
In the current study, we aimed to address some of 
the limitations of previous research by recruiting only 
patients with DM with clear evidence of a recent MI, 
regardless of their chest pain presentation and use of a 
qualitative methodology to explore how these patients 
describe their symptoms. Qualitative methods can help 
overcome a narrow clinician focus and help develop 
a patient-oriented view when exploring symptoms of 
disease.23 36 39 40 The aim of the study was to investigate the 
symptoms people with diabetes experience when having 
an MI, their illness narrative and how they present their 
symptoms to the health service.
MethODs
This was a qualitative study where interviews were under-
taken with patients with DM who have recently had a 
confirmed MI, recruited within coronary care units 
(CCUs). Eligibility criteria included a confirmed diag-
nosis of MI (according to American Heart Association 
criteria41), a clinical diagnosis of DM and the ability to 
communicate (understand and speak) enough English 
to complete the interview. Clinical staff identified partic-
ipants and ensured that they were post-treatment, clini-
cally stable and well enough to participate. This subjective 
judgement was made by the clinical staff involved in 
participants’ care as required by the ethics committee. 
Participants were approached as soon as possible after 
the diagnosis by a researcher (NB) so we could be sure 
that they had had an MI (usually a retrospective or 
working diagnosis) and to minimise recall bias about 
symptoms. Once invited, they were given a patient infor-
mation sheet about the study and 24 hours to decide 
whether to participate (see comments regarding ethics 
approval). The interviews took place in three London, 
UK hospitals. We aimed to recruit consecutive patients 
(but this proved unworkable) so this was a pragmatic 
sample.42
The interviews were semistructured and iterative 
building from a topic guide to include a narrative of the 
course, range, character and severity of the symptoms the 
person experienced before and during their MI. We used 
a checklist of acute MI (AMI) symptoms based on Funk’s 
acute AMI symptom list.15 This is distinct to Diamond and 
Forrester’s classification of angina typicality.43 The check-
list was worked through to ensure that symptoms were 
absent and not just omitted. Ideas about expected symp-
toms of an MI and symptom attribution were also explored 
as people often develop complex narratives about their 
illnesses.44 We also explored participants’ thoughts about 
their illness, treatments they had attempted, motives and 
triggers for seeking help and awareness and knowledge of 
the symptoms of a heart attack.
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Interviews were audio recorded, and field notes and 
baseline patient information were noted. Details gath-
ered included the type of MI (ECG changes, troponin 
level and clinical assessment), the patients’ demographics, 
comorbidities (type and duration of DM, other disease), 
risk factors, family history, medication use and informa-
tion that might impact on symptom perception, from 
the informant and their medical records. All participants 
were allocated a code number to link their data together 
and then anonymised (apart from the consent form) so 
that identifiable data did not leave the ward setting.
The audio taped interviews were transcribed verbatim 
and manually analysed using a thematic framework 
approach,22 45 using word processing and spreadsheet 
software. Agreement was specifically sought between 
reviewers about the classification of symptoms as either 
typical or atypical as outlined by Funk.15 Two independent 
researchers (NB, DADC) read the transcripts and anal-
ysed the data using the following steps: familiarisation, 
identifying a thematic framework, indexing, charting, 
mapping and interpretation. Throughout this process, 
transcripts were repeatedly re-read to focus on specific 
points and ideas, to verify the presence of the themes 
and subthemes that were identified and to ensure that 
the context of the themes had been preserved. There 
was then a dialogue between all the researchers which 
was reflexive in nature linking the findings back to the 
study’s aims. The analysis was deductive or theoretical 
in approach in that we were looking for themes around 
diabetes and MI and those bounded by an expectation 
of probable reduced or absent pain symptomatology, 
and this shaped our topic guide and approach to the 
data. However, the analysis was also inductive in nature, 
in that we needed to derive themes from the data, in as 
much that if there were no pain symptoms during the 
MI, we needed the participants and their narratives to 
tell us what they did experience. The themes around 
reporting of symptoms are semantic (or a surface 
meaning) in that we are largely reporting the partici-
pants’ descriptions of their experience. However, the 
explanatory models around what participants thought 
caused their symptoms and reactions to those symptom 
are much more latent thematic or interpretive analysis.22 
Representative quotes (with consent) were used and 
have identifying details to link the theme to the partici-
pants’ characteristics.
The lay term ‘heart attack’ is used extensively in the 
transcripts; this can have a broad popular meaning but 
we will assume that this is used by participants to suggest 
an MI.
Ethical approval for this study and the use of quotes 
was obtained from the Hertfordshire Research Ethics 
Committee (project 11/EE/0045). The committee 
requested that we allowed a ‘cool off’ period of 24 hours 
from approach to obtaining consent. Data protection 
and local hospital trust research and development poli-
cies were followed. Consent was not originally sought to 
disclose the full interview transcripts.
Patient involvement
The original idea for this study was based on a clinical 
encounter in general practice. A patient consulted MMJ, 
his general practitioner, having had a severe MI despite 
having minimal symptoms and subsequently developed 
severe heart failure. Before his death, this patient agreed 
to support research in this area and filmed a brief video 
of his experiences. A broader study (with same research 
question but a different methodology) on this field was 
presented and supported by the North East London 
Diabetes Research Network Lay Panel Meeting in 2011. 
Patients’ narratives constitute the data underlying this 
study.
results
Forty-three participants were recruited from the partic-
ipating hospitals; however, four interviews proved unus-
able due to not meeting study recruitment criteria on 
detailed case review and were excluded, resulting in a 
total of 39 participants’ data available for analysis. Data 
on those who declined to participate were not recorded 
as it would have placed an additional burden on ward 
staff. The interviews had a mean duration of 20 min 33 s 
(with a range from 5 min 14 s to 48 min 46 s) and were all 
undertaken by one interviewer: NB. The study comprised 
30 men and nine women, with an age range of 40–90; 
35 participants had type 2 DM and four had type 1 DM. 
All participants had confirmed acute coronary syndrome; 
24 had non-ST elevated MIs, 10 had ST elevated MIs and 
five had other MIs (acute MI unspecified including four 
cardiac arrests) (see table 1). Their ethnic categories were 
white British (n=18), Asian/South Asian (n=7), African 
or Afro-Caribbean (n=3) and others (n=5) (eg, Turkish, 
Maltese and so on). A number (n=6) declined to state 
their ethnicity or instead identified their religious affilia-
tion (eg, ‘Church of England’, ‘Jewish’ and so on). One 
interview was done via an informal family translator but, 
family members would participate in the interview (in two 
interviews), clarifying the order of events or reminding 
the participant about elements of their illness narrative 
(which may have been clouded by their illness including 
cardiac arrest or treatment such as strong opioid analge-
sics). Participants were usually approached to participate 
the day following admission or the Monday following a 
weekend admission and then interviewed usually the 
following day after consenting to participate as per our 
ethics approval. Data saturation was achieved. Each 
participant was given a study number between 1 and 43 
and quotes are linked (eg, participant 22 (P22)).
themes
The analysis of the data led to the identification of the 
following themes and subthemes.
Symptoms
 ► Typical versus atypical presentations
 – Atypical presentations
 ► Absence of pain
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Table 1 Description of participants
Participant Age range (years) Type of DM Duration of DM range (years) Treatment of DM Type of MI
1 70–79 2 10–19 OHG NSTEMI
2 50–59 2 10–19 OHG/In NSTEMI
3 80–89 2 10–19 OHG/In Acute MI unspecified
4 40–49 2 0–9 OHG NSTEMI
5 70–79 2 20–29 OHG NSTEMI
6 50–59 2 10–19 In NSTEMI
8 70–79 2 10–19 OHG Acute MI unspecified
10 70–79 2 10–19 OHG/diet STEMI
11 50–59 1 10–19 In STEMI
13 60–69 2 NR OHG/In NSTEMI
14 80–89 2 0–9 OHG STEMI
15 60–69 2 0–9 OHG STEMI
16 70–79 2 0–9 OHG NSTEMI
17 60–69 2 >10 OHG+ NSTEMI
18 70–79 2 NR Acute MI unspecified
19 60–69 1 40–49 In NSTEMI
20 80–89 2 0–9 OHG NSTEMI
21 70–79 2 >10 OHG Acute MI unspecified/
cardiac arrest
22 60–69 2 NR OHG NSTEMI
23 60–69 2 0–9 OHG Acute MI unspecified/
cardiac arrest
24 70–79 2 10–19 OHG NSTEMI/cardiac arrest
25 70–79 2 >25 OHG/In STEMI
26 50–59 2 10–19 OHG/In STEMI
27 70–79 2 0–9 OHG STEMI/cardiac arrest
29 50–59 1 30–39 In NSTEMI
30 60–69 2 10–19 OHG+/In NSTEMI
31 40–49 2 0–9 OHG STEMI
32 80–89 2 >20 OHG+ NSTEMI
33 60–69 2 10–19 OHG+ STEMI
34 60–69 2 10–19 OHG STEMI
35 50–59 2 0–9 Diet NSTEMI
36 40–49 2 20–29 OHG/In NSTEMI
37 60–69 2 0–9 NSTEMI
38 70–79 2 10–19 OHG NSTEMI
39 50–59 2 10–19 OHG/In NSTEMI
40 40–49 1 30–39 OHG/In NSTEMI
41 90–99 2 30–39 In NSTEMI
42 50–59 2 0–10 OHG NSTEMI
43 60–69 2 10–19 OHG NSTEMI
Cases 7, 9, 12 and 28 are not included as they did not meet study criteria.
Treatment key: OHG, oral hypoglycaemics (eg, metformin/glicazide and so on); In, insulins; OHG+, oral hypoglycaemics+other drugs, for 
example, gliptins/glitazones.
DM, diabetes mellitus; MI, myocardial infarction; NSTEMI, non-ST elevated MI; STEMI, ST elevated MI.
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Attribution and consequences
 ► Attributing symptoms to comorbidities
 – Ascribing symptoms to DM
 – Ascribing symptoms to hypoglycaemia
 ► Delay in seeking help
 ► Gradual onset of symptoms
 – Multiple symptoms
 ► Lack of awareness of MI symptoms or their increased 
risk of MI
 – Experience of repeat MIs
 ► Language of pain
 ► Knowing ‘something was wrong’
However, these themes are not distinct. The nature 
of obtaining patients’ narratives means that there are 
complex, inseparable relationships in concepts and ideas, 
with a continuum across themes and subthemes.
Symptoms
Participants described a wide range of symptoms, 
primarily around chest pain and discomfort. However, 
other symptoms associated with MI such as sweating 
and breathlessness were described, as well as a series of 
symptoms that are not usually associated with MI presen-
tations. With regard to chest pain, we found a range of 
symptom presentations.
Typical versus atypical presentations
Chest pain of a specific character is regarded as the 
classic symptom of MI and was present in most of these 
interviews.
It was like your chest was being crushed. (P3)
Many of these descriptions catch this essence of a 
typical MI.
Err a real dull ache and like someone is screwing 
up, like a tight chest just really tight, like someone 
is squeezing it inside…yeah like a really, really dull 
pain’…‘it started hurting and made me feel really 
ill…but then I went really pale and started sweating…
absolutely saturated. just a really tight chest and sore 
like, as if there was a weight directly on top of me. (P 
11)
Most of those in the study experienced some typical 
symptoms. However, typical symptoms with a recent chro-
nology (necessary to suspect MI) were not always present 
or immediately apparent in the interviews.
Some experienced sweating, regarded as a typical MI 
symptom.
My night clothes were soaking wet. (P3).
Breathlessness was also experienced either with pain or 
separately, which, although classed as a ‘typical’ symptom 
[23], is not generally recognised by clinicians to be 
suggestive of an MI.
I can’t breathe, you couldn’t breathe, my wife she 
phone a medic…No you got the pain and you can’t 
breathe…you think you’re gonna die for the lack of 
breath. (P14)
Like somebody’s pushing me…and I’m short of 
breath and then it was getting worse and it start 
burning. (P35)
Atypical pain
Some of those in this study sometimes narrated their 
experience of a diffuse and ambiguous set of symptoms 
that may not raise suspicion of MI.
It feels like something crawling up my arm…and it 
bites deep in there…the only way I can describe it, it 
feels like someone is in there with claws and they’re 
tearing at your inside. Just screaming and pulling at 
it. Very, very strange pain indeed. (P24)
Although this person later describes quite typical 
sounding symptoms. Others described the quality of their 
pain.
It was just sticking pain, it was just a really pain, stay 
there for about 3 hours. (P30)
Like a normal pain, it wasn’t a pain, actually it was 
dull. (P26)
These quotes raise the issue of participants’ use of 
language which is discussed later.
The following quote illustrates a mixture of some 
typical and atypical symptoms:
I can feel something happening you know, my chest, 
had very bad pain in my arm, my neck and my leg, 
I couldn’t move…Yeah sharp pain, very sharp…
Somebody was pressing my, you know, chest…My 
back…All the way up to the waist…I couldn’t breathe 
you know. I get very deep breath, I tried to do it but it 
didn’t go, somebody was choking me. (P5)
The inseparability of these two types of symptoms 
(typical/atypical) is raised in the discussion.
Symptoms of weakness and tiredness were also reported 
around the timing of the MI. One participant could not 
walk and said,
It’s just the sheer um lethargy really, I just couldn’t 
do anything…I wasn’t giddy and I wasn’t in a lot of 
pain, I just couldn’t sort of come to, I was, I couldn’t 
put one foot in front of the other. I was just so weak. 
(P10)
Absence of pain
Some clearly stated they had no chest pain,
Nothing, nothing, no discomfort, no pain (pre 
cardiac arrest). (P27)
 but this participant did have pain after being resusci-
tated. Another reported
No pain, no sweating, nothing else (pre cardiac 
arrest). (P23)
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Both of these participants experienced cardiac arrests, 
so some degree of event amnesia cannot be excluded.
Attribution and consequences
Attributing symptoms to comorbidities
The participants seemed to rationalise their symptoms 
and find a reason to dismiss that the cause of their symp-
toms could be a ‘heart attack’. Many attributed their 
symptoms to other illness and causes. Most commonly, 
they attributed their symptoms to indigestion leading to 
self-medication with antacids for this,
when you feel bloated and gassy and it’s similar to 
that sort of pain. That’s why I mistook it for being 
indigestion…. I put it down to nerves or exercise…
but then in the early hours of Sunday morning I 
realised it couldn’t have been indigestion because it 
was paining me a great deal. (P31)
I took, bicarb of soda, didn’t work. I took um Gaviscon 
(antacid remedy), didn’t work. The antibiotics didn’t 
work. That’s when I knew, there was more to this. (P3)
But symptoms were also attributed to other causes that 
included asthma, muscular aches, panic attacks, stress 
and, importantly in this group, their DM.
Because of, I have other illness(es), like blood 
pressure, diabetes, I didn’t think (of MI), because I 
thought there is nothing wrong with my heart. (P4).
These quotes also link to the theme of delay (both by 
patient and by clinician) which is discussed further on.
Ascribing symptoms to DM
Participants sometimes specifically attributed their symp-
toms to (lack) of control of their DM, symptoms of DM or 
side effects of their medication.
I didn’t realise I was having heart attack, so I was 
feeling rotten…I was hungry. Well I wasn’t really 
hungry but I know, don’t, diabetic,…that’s when 
the pain come, and I went to bed and it woke me up 
around two in the morning. (P17)
Well dizzy, tired, again I’m dizzy all the time with 
diabetes, you get that, that’s part and parcel of being 
diabetic. (P17)
Participant 3 also attributed her dizziness during her 
MI to her DM.
Not fainting, but you know dizzy turns, because I do 
get these dizzy turns. You see, this is all in with the 
diabetes you see. (P3)
Ascribing symptoms to hypoglycaemia
Patients when experiencing some symptoms, particularly 
sweating and feeling unwell, perceived themselves to be 
experiencing hypoglycaemia (‘Hypo’), for example,
because I am diabetic, right, um, I thought, initially I 
thought it was um low blood sugar. (P2.)
A little (of sweating) bit, but…I didn’t have my testing 
gear with me and I thought that it might be a hypo at 
the time. (P11)
Participant 3 perceived herself to be experiencing 
hypoglycaemia.
That’s when I knew, there was more to this (symptoms) 
and I had, I don’t know whether I had five hypo’s in 
that week, but I was rolling all over the place. (P3).
Delay in seeking help
Delay in help seeking was a prominent feature in these 
narratives.
I think to be honest it (chest pain) came on suddenly 
but I tended to ignore it, I’ve got one more screw to 
put in. (P21)
I waited till my GP opened in the morning. I called 
him and I told him what’s wrong, they said ‘just phone 
the ambulance. (P5).
This delay could be ascribed to participants’ failure 
to attribute symptoms to MI, attribution to comorbidi-
ties, lack of symptom awareness or lack of awareness of 
increased risk of MI, but participants often realised that 
something more serious was occurring when their symp-
toms did not improve.
But it was there too long, so I said ‘could be heart 
attack. (P30)
Often participants had dismissed or explained away 
these one off or minor symptoms and did not think much 
of them, except with hindsight.
more during the week. Nothing sharp…it was just a 
niggling thing, it just came and then it went away…
you just didn’t think too much of any of these factors 
in isolation; but together. (P31)
With others, denial was behind their delay.
Well I thought it was a heart attack but I didn’t really 
want to admit it at the time. Anything other than a 
heart attack. (P17)
Gradual onset of symptoms
For some participants, part of this delay was the gradual 
rather than sudden onset of symptoms.
‘Well no…it had happened a fortnight before’…‘Sat 
in the chair for about 20 min and then it went so 
then I said to my wife, I told her ‘If it happens again I 
would be calling the doctor’. (P20)
Multiple symptoms
The respondents often had complex narratives where 
chest pain was a part of the symptom complex they 
described, but their chest pain symptom may not have 
been the most prominent, important or distressing 
feature, exemplified by the following quote.
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It (chest pain) did come on suddenly…at the same 
time I had this very heavy perspiration…and this 
very uncomfortable tummy ache…Err all three 
things hitting me at once; you don’t pick one out in 
particular…all those three factors the er tummy ache 
the excessive err sweating and the pain in the chest 
um I could point to one and say look that was the 
main problem. they were all a problem at that short 
period of time. (P 25)
Lack of awareness of MI symptoms or their increased risk of MI
Many of these respondents, despite having long-standing 
diabetes, previous cardiac events or a strong family 
history, seemed unaware that they were at a high risk of 
subsequent MI.
I thought…how can I have a heart attack? Right. But 
you see, this might be relevant as well; both my side of 
my family, my mother’s side and my father’s side are 
diabetic. My father had a heart attack as well and he 
died from it. My mother had a triple heart bypass. My 
elder brother’s had an angioplasty, right, so it does 
run in the family. (P2)
Experiences of a repeat MI
Participants who had previous MIs might be expected to 
have a good working knowledge of these symptoms and 
respond accordingly if it recurred. We found, however, 
that often they did not do so.
I should have guessed, right, um, it’s exactly the same 
symptoms as when I had my first heart attack. (P2)
Language of pain
The expectation of severe chest pain is key to many 
patients’ and doctors’ model of what an MI should be 
like and is apparent in some of the previous themes. 
However, many of these respondents had symptoms that 
they did not feel reached a threshold of severity that they 
would call ‘pain’.
I suppose people would call it a pain, I don’t know, I 
wouldn’t, I would still call it severe discomfort…dull, 
rather than, no it wasn’t sharp…. I won’t put it (pain 
severity score) higher, otherwise I probably would 
have called an ambulance straight away. (P20)
No, it was a constant. When I say pain, ache, it wasn’t 
a pain that was making me double up or anything. 
(P25)
While some struggled to conceptualise their symptoms 
as pain, others struggled to use words to describe their 
symptoms.
It’s so difficult cos it was more uncomfortable than 
a pain that you can describe…I don’t know how to 
describe it. (P20)
While others clearly had very significant pain but still 
struggled to articulate it,
Indescribable to me, I couldn’t, as I sit here I can’t 
describe it…I had severe pain and it was; I don’t know 
how you break it down into words. (P19)
Knowing ‘something is wrong’
Frequently participants had a ‘gut feeling’ that there was 
something wrong or a strong emotional response to their 
symptoms.
You know, I could sort of feel that there was something 
wrong. (P2).
And I thought I can’t do this, I got to get ‘elp’, and 
that’s when I dialled 999… and, you know, everything 
was going wrong, and I just couldn’t figure out. (P3).
A ‘sense of doom’ is often associated with the pres-
entation of MI, but in this group, only a few participants 
reported a strong sense of impending death.
I felt as if I was going to die (anxious voice). (P6)
DiscussiOn
We found that patients with DM who experienced an MI 
exhibited a wide range of symptoms from very classical 
presentations to very mild symptoms.23 Patients often 
were unclear what caused their symptoms.46 This diag-
nostic confusion or uncertainty appears periodically to 
have been mirrored by clinicians.9 24
The symptoms experienced in this group ranged from 
those that may be expected by healthcare professionals 
to more atypical symptoms with patients using unusual 
descriptive terms. The variation in experiences highlights 
the difficulty for both patients and healthcare providers 
to correctly attribute these symptoms to a cardiac event.
Patients with DM will often have other significant 
comorbidities which can be attributed to their symptoms, 
for example, breathlessness from chronic obstructive 
pulmonary disease rather than an MI. However, there 
seems to be an important area of confusion from symp-
toms related to DM and its control, that can lead to a 
misattribution of pain symptoms away from a new onset 
MI. A specific issue among this group is the impact of MI 
symptoms which were perceived as a side effect of medica-
tion (particularly insulin and oral hypoglycaemics). Inter-
preting episodes of hypoglycaemia and sudden onset MI 
seems to be particularly challenging with an overlap of 
many similar symptoms and their sudden onset.25
We found that participants had a lack of knowledge of 
MI symptoms, were falsely reassured by the lack of severe 
pain or did not conceptualise their milder chest discom-
fort as chest pain. These factors may all lead to denial or 
confusion and therefore delay in seeking care.33 Delay in 
seeking medical attention during an MI will have signifi-
cant prognostic implications.
As the participants’ symptoms did not fit with their 
preconceived ideas of an MI,25 they ascribed it to other less 
serious causes, or importantly attributed their symptoms 
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Figure 1 How diabetes (grey boxes) might affect the ‘health belief model’ during MI. (adapted from Strecher and 
Rosenstock.48). DM, diabetes mellitus; IHD, ischaemic heart disease; MI, myocardial infarction.
to their DM, medication side effects or ‘hypos’, which is a 
novel and important finding. The attenuated chest pain 
competing with other, perhaps more distressing symp-
toms and so being ‘crowded out’ from the illness cogni-
tion of a possible MI, has not been previously reported.
strengths
Within this study, we have reported contemporaneous 
symptoms from a well-described patient group, who can 
be characterised by their MI diagnosis. We have captured 
a wide range of participants with MI, by using biochem-
ical confirmation of diagnosis wherever possible and by 
including clinical diagnoses (eg, for cardiac arrests). 
Unusually for a qualitative study, we have a relatively large 
number of participants, who were interviewed as early as 
possible (or allowed to) after the event to reduce recall 
bias.47
limitations
Despite recruiting participants on the basis of their MI 
diagnosis, but not specifically on chest pain presenta-
tions, participants are likely to have initially volunteered 
chest pain symptoms to get admitted to a CCU. Markedly 
discrepant MI narratives are less likely to be represented 
in this study, as are silent MIs, as they are more likely to 
go unrecognised and present late. Survivor bias is also 
a distinct possibility.21 While a study size of 39 is good 
for qualitative research,47 it is small in comparison with 
epidemiological studies so this methodology is therefore 
unlikely to pick up rarer presentations of MI.
Recruiting on the basis of being able to converse 
in English will exclude the linguistic nuance of other 
languages and cultures, important when South Asian 
populations among others have a high risk of DM and 
CHD. However, we did successfully capture many patients 
who had English as second language. In addition, the 
UK National Health Service struggles to provide reli-
able, accessible translation, particularly, in the acute 
and out-of-hours setting, so our findings may more faith-
fully reflect the real-world setting of these decisions and 
presentations.
Truncating these interviews into quotes also runs the 
danger of falsely dichotomising symptoms into ‘typical’ 
and ‘atypical’. When the transcripts are read in full and 
in context, a more rounded picture of the event develops. 
This nuanced view is probably a key element that helps 
experienced clinicians successfully identify a potential 
MI, in this group of patients.
how this fits into existing literature
The findings of our study link with previous work within 
a broad context of psychological models of illness 
behaviour such as health belief models.48 We have used 
our findings to adapt Strecher, Rosenstock and Kirsch’s 
health belief model48 (see figure 1) so that the impact of 
DM can modify the steps in the model such as reduced 
pain from neuropathy during an MI reducing the likeli-
hood of action.
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The language of describing pain and particularly the 
difficulty of describing pain recurs within our sample. 
Scarry describes this as the ‘inexpressibility of pain’49 and 
this is seen with some respondents. Others use metaphor 
and simile to circumvent this issue, which may be helpful 
to the patient but means that a clinician might cogni-
tively process such symptom descriptions as ‘atypical’ or 
‘non-cardiac’, leading to misdiagnosis and delays in treat-
ment. The term ‘chest pain’ is also problematic37; many 
of these participants did not conceptualise their chest 
symptoms as pain and so Miller has suggested using the 
term ‘chest sensation’ instead.50
Our findings have some similarities to other studies 
about patients’ experiences of MI.23–26 The similarity of 
symptom presentation raises the possibility that these 
studies are just capturing the heterogeneous array of MI 
symptoms and this is unlinked to any underlying physi-
ological or pathological process such as gender or DM. 
However, our finding of patient misattribution of MI 
symptoms to DM and diabetic medication, in a group at 
high risk of MI, does have significant clinical implications 
for patients and clinicians.
implications for further research
Despite knowing that people with DM are at much higher 
risk of coronary events, we fail to inform patients in the 
UK about their increased cardiovascular risk nor iden-
tify early those who may be developing such problems. 
Whether screening people with diabetes for ischaemic 
heart disease would be beneficial remains a key question. 
Possibilities include trialling patient education about 
their CHD risk and its presentation in the UK Quality 
and Outcome (Quality and Outcomes Framework) DM 
check or including this information within DESMOND 
( desmond- project. org. uk)/DAFNE (www. dafne. uk. com) 
patient education programmes, but there would be consid-
erable difficulty in designing an educational package that 
could reliably help patients distinguish between these two 
aetiological possibilities of ‘hypo’ versus MI.
implications for practice
This study could contribute towards increased awareness 
of MI in those with DM. Patients with DM should be made 
aware of their increased risk of cardiac events, how they 
present and how they differ from medication side effects 
and ‘hypos’. Clinicians should carefully explore the symp-
toms of patients with diabetes as well as their interpreta-
tion of their symptoms.
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